Project/Area Number |
25670463
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Infectious disease medicine
|
Research Institution | University of Toyama |
Principal Investigator |
MURAGUCHI Atsushi 富山大学, 大学院医学薬学研究部(医学), 教授 (20174287)
|
Co-Investigator(Renkei-kenkyūsha) |
KISHI Hiroyuki 富山大学, 大学院医学薬学研究部(医学), 准教授 (60186210)
OZAWA Tatsuhiko 富山大学, 大学院医学薬学研究部(医学), 助教 (10432105)
KOBAYASHI Eiji 富山大学, 大学院医学薬学研究部(医学), 助教 (70459733)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Project Status |
Completed (Fiscal Year 2015)
|
Budget Amount *help |
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 感染症 / 癌治療 / リンパ球チップ / 抗体 / T cell receptor / T Cell Receptor |
Outline of Final Research Achievements |
We developed a rapid and efficient antibody gene cloning system from a human single B lymphocyte. In this study, by applying the system to T cell receptor, we have developed a rapid and efficient T cell receptor cloning system (hTEC10: human T cell receptor efficient cloning within 10 days),in which we are able to detect an antigen-specific T cells, to clone efficiently TCR-alpha and TCR-beta chain from a single T cell, and finally evaluate the function of T cell receptor by examining reactivity of specialized T cell line (TCR negative cell line). All of the process can be done within 10 days. Using this hTEC10 system, we have been successful in cloning the functional TCRs with high killer activity from peripheral blood lymphocytes of patients with hepatocyte cell carcinoma. This system may contribute TCR gene therapy of infectious diseases as well as various cancers.
|